Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127776321 | 12777632 | 1 | I | 20160908 | 20160912 | 20160924 | 20160924 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-59984BP | BOEHRINGER INGELHEIM | 91.90 | YR | F | Y | 0.00000 | 20160924 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127776321 | 12777632 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | N | 602216 | 22512 | 150 | MG | CAPSULE | BID | ||||
127776321 | 12777632 | 2 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | N | 602216 | 22512 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127776321 | 12777632 | 1 | Cerebrovascular accident prophylaxis |
127776321 | 12777632 | 2 | Atrial fibrillation |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127776321 | 12777632 | Back pain | |
127776321 | 12777632 | Chest pain | |
127776321 | 12777632 | Dyspepsia | |
127776321 | 12777632 | Neck pain | |
127776321 | 12777632 | Oropharyngeal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127776321 | 12777632 | 1 | 20160906 | 20160907 | 0 |